A New Era in Cervical Cancer Screening

  • Credit:1.0 ACCENT
  • Duration: 60 minutes
  • Date:JUL.17.2014 2:00 PM - 03:00 PM

Price: $0.00

Member Price: $0.00

Rating: Member Average

Description

New clinical trial data comparing cervical cancer screening methods led to the recent FDA approval of an HPV DNA test as a primary screen in women 25 and older—just the latest development in this dynamic area of laboratory testing. Join AACC for this 60-minute FREE webinar, supported by an educational grant from Roche Diagnostics, and hear Mark H. Stoler, MD, discuss the new data and what it means for the future of cervical cancer screening, what constitutes a "clinically validated" HPV test, and what the advantages and limitations of using today's FDA-cleared HPV testing technologies are in the context of these new developments. 

Speaker Presentation Description

mark stolerMark H. Stoler, MD, Professor (Emeritus) of Pathology, Cytology and Gynecology; and Director, Gynecological Pathology Fellowship Program, University of Virginia, Charlottesville, VA

Target Audience

Laboratory administrators, directors, and managers; cytopathologists; molecular pathologists; clinicians; and IVD industry professionals  involved in cervical cancer screening or HPV testing.

Program

New data from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) clinical trial spurred the FDA to recently approve for the first time an HPV DNA testing algorithm for women 25 and older as a primary screen for cervical cancer, and this approval will likely have an impact on guideline development moving forward. For now, though, what are the best practices for cervical cancer screening?

During this 60-minute webcast, Mark H. Stoler, MD, discusses current thinking on primary screening for cervical cancer, including what data from the ATHENA trial tell us about various methods used to perform cervical cancer screening; what the current guidelines are for cervical cancer screening and how they predict risk; and what it means to have a “clinically validated” HPV test.

Continuing Education

Obtain Your ACCENT Credit Here After Viewing the Program (Login = 9100; Password = hpvtest)

By claiming continuing education credit for this activity, you are affirming that you have participated in this activity in its entirety.

Speaker Biography

Dr. Stoler is an internationally recognized expert in Cytopathology, Gynecologic pathology and HPV biology. He received his initial training in pathology at the University of Rochester where he also received his undergraduate and medical school training.  Following a specialized fellowship consisting of both surgical and cytopathology as well as molecular biology, he was appointed to the faculty of the University of Rochester from 1985-1989. In 1989, he moved to the Cleveland Clinic Foundation where he served as Staff Pathologist and the Medical Director of the Histology Laboratory.  In 1993, Dr. Stoler was recruited to the University of Virginia. Dr. Stoler is the author or co-author of over 177 peer-reviewed publications and several book chapters. He is editor-in-chief of both Diagnostic Molecular Pathology, and the International Journal of Gynecological Pathology and is an Associate Editor for the 4th Edition of Sternberg's Diagnostic Surgical Pathology, the leading textbook of surgical pathology.

System Requirements

To access this webcast, you will need a computer with Internet access and speakers, a compatible Internet browser (e.g., Internet Explorer), and a compatible version of the Flash plug-in. To see if your browser, Flash plug-in and system meet the minimum requirements please visit the Adobe System Requirements page.

Supported By

Roche 2014 Logo